Alnylam Pharmaceuticals
ALNY
#601
Rank
ยฃ25.62 B
Marketcap
ยฃ197.97
Share price
-5.28%
Change (1 day)
61.98%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ5.32 M-87.67%
2024ยฃ43.18 M-16.96%
2023ยฃ51.99 M-66.55%
2022ยฃ0.15 B200.46%
2021ยฃ51.74 M-9.83%
2020ยฃ57.38 M52.34%
2019ยฃ37.66 M46.52%
2018ยฃ25.7 M-70.97%
2017ยฃ88.54 M191.96%
2016ยฃ30.32 M-14.94%
2015ยฃ35.65 M68.07%
2014ยฃ21.21 M152.1%
2013ยฃ8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ยฃ3.12 Mยฃ10.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.08 Mยฃ50.67 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.5 Mยฃ36.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.94 Mยฃ53.85 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.19 Mยฃ6.67 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.68 Mยฃ0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ6.86 Mยฃ53.59 M๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ13.08 Mยฃ42.43 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel